Liberum Capital reissued their buy rating on shares of Assura PLC (LON:AGR) in a report issued on Monday, August 7th, reports. They currently have a GBX 68 ($0.88) price objective on the real estate investment trust’s stock.

Separately, Peel Hunt reissued a hold rating and set a GBX 55 ($0.71) price objective on shares of Assura PLC in a report on Tuesday, June 20th.

Shares of Assura PLC (AGR) opened at 64.00 on Monday. The company’s market cap is GBX 1.06 billion. The company has a 50 day moving average price of GBX 63.39 and a 200 day moving average price of GBX 60.47. Assura PLC has a 52 week low of GBX 51.35 and a 52 week high of GBX 65.00.

ILLEGAL ACTIVITY WARNING: “Assura PLC (AGR) Rating Reiterated by Liberum Capital” was originally published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this piece on another site, it was copied illegally and republished in violation of U.S. and international copyright laws. The correct version of this piece can be read at

The company also recently disclosed a dividend, which was paid on Wednesday, July 19th. Shareholders of record on Thursday, June 15th were issued a dividend of GBX 0.60 ($0.01) per share. This represents a yield of 1.01%. The ex-dividend date of this dividend was Thursday, June 15th.

Assura PLC Company Profile

Assura plc is a United Kingdom-based healthcare real estate investment trust (REIT). The Company is a primary care property investor and developer. The Company develops, invests and manages a portfolio of primary care medical centers across the United Kingdom. The Company’s property portfolio includes Alwoodley Medical Centre, Leeds; Fleetwood Health and Wellbeing Centre, Fleetwood; Frome Medical Practice, Frome; Claremont Medical Centre, Surbiton; Elbury Moor Medical Centre; Grey Gable Surgery; Trellech Surgery; Bewdley Medical Centre; Malmesbury Primary Care Centre, Malmesbury, and Urmston Group Practice, Urmston.

Stock Target Prices

Receive News & Stock Ratings for Assura PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Assura PLC and related stocks with our FREE daily email newsletter.